Flow cytometric analysis of DNA ploidy and S-phase fraction of Stage IIIB cervical carcinoma

European Journal of Gynaecological Oncology

Volumn 25, Issue 4, 2004, Pages 428-430

  Wilailak, S ^a   Rochanawutanon, M ^a   Srisupundit, S ^a   Aumkhyan, A ^a   Pattanapanyasat, K ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cervical carcinoma; DNA ploidy; S phase fraction

Indexed keywords

ADULT; AGED; CALCULATION; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIPLOIDY; EVALUATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; KAPLAN MEIER METHOD; LIFE TABLE; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATHOLOGICAL ANATOMY; PLOIDY; RETROSPECTIVE STUDY; REVIEW; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANEUPLOIDY; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; PLOIDIES; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; S PHASE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 3242724338     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Lunt R.: "Worldwide early detection of cervical cancer". Obstet. Gynecol., 1984, 6, 708.
2. Annual Report 2001. Planning and Statistics Division, National Cancer Institute, Department of Medical Service, Ministry of Public Health. Bangkok, 2001, 6.
3. Stehman F.B., Bundy B.N., DiSaia P.J., Keys H.M., LarAson J.E., Fowler W.C.: "Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group". Cancer., 1991, 67, 2776.
4. Kimming R., Wimberger P., Hillemanns P., Kapsner T., Caspari C., Hepp H.: "Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells". Gynecol. Oncol., 2002, 84, 21.
5. Merkel D.E., Dressler L.G., McGuire W.L.: "Flow cytometry, cellular DNA content, and prognosis in human malignancy". J. Clin. Oncol., 1987, 5, 1690.
6. Bauer K.D., Lincoln S.T., Vera-Roman J.M. et al.: "Prognostic implications of proliferative activity and DNA aneuploids in colonic adenocarcinoma". Lab. Invest., 1987, 57, 329.
7. Konski A., Domenico D., Irving D. et al.: "Flow cytometric DNA content analysis of paraffin-embedded tissue derived from cervical carcinoma". Int. J. Radiat. Oncol. Biol. Phys., 1994, 30, 839.
8. Kristensen G.B., Kaern J., Abeler V.M., Hagmar B., Trope C.G., Pettersen E.O.: "No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: A prospective study of 465 patients". Gynecol. Oncol. 1995, 57, 79.
9. Jelen I., Valente P.T., Gautreaux L., Clark G.M.: "Deoxyribonucleic acid ploidy and S-phase fraction are not significant prognostic factors for patients with cervical cancer". Am. J. Obstet. Gynecol., 1994, 171, 1151.
10. Zanetta G.M., Katzmann J.A., Keeney G.L., Kinney W.K., Cha S.S., Podratz K.C.: "Flow-cytometric DNA analysis of Stages IB and IIA cervical carcinoma". Gynecol. Oncol., 1992, 46, 13.
11. Strang P., Stendahl U., Bergstrom R., Frankendal B., Tribukait B.: "Prognostic flow cytometric information in cervical squamous cell carcinoma: A multivariate analysis of 307 patients". Gynecol. Oncol., 1991, 43, 3.
12. Jacobsen A.: "Prognostic impact of ploidy level in carcinoma of the cervix". Am. J. Clin. Oncol., 1984, 7, 475.
13. Nguyen H.N., Sevin B.U., Averette H.E. et al.: "The role of DNA index as a prognostic factor in early cervical carcinoma". Gynecol. Oncol., 1993, 50, 54.
14. Lai C.H., Hsueh S., Huang M.Y., Chang M.F., Soong Y.K.: "The uses and limitations of DNA flow cytometry in Stage IB or II cervical carcinoma". Cancer., 1993, 72, 3655.
15. Graflund M., Sorbe B., Bryne M., Karlsson M.: "The prognostic value of a histologic grading system, DNA profile, and MIB-1 expression in early stages of cervical squamous cell carcinomas". Int. J. Gynecol. Cancer., 2002, 12, 149.
16. Horn L.C., Raptis G., Nenning H.: "DNA cytometric analysis of surgically treated squamous cell cancer of the uterine cervix, stage pT1b1-pT2b". Anal. Quant. Cyto. Histol., 2002, 24, 23.
17. Connor J.P., Miller D.S., Bauer K.D., Murad T.M., Rademaker A.W., Lurain J.R.: "Flow cytometric evaluation of early invasive cervical cancer". Obstet. Gynecol., 1993, 81, 367.
18. Hedley D.W., Friedlander M.L., Taylor I.W., Rugg C.A., Musgrove F.A.: "Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry". J. Histochem. Cytochem., 1983, 31, 1333.
19. Hiddemann W., Schumann J., Andreef M. et al.: "Convention on nomenclature for DNA cytometry. Committee on nomenclature, Society for analytical cytology". Cancer. Genet. Cytogenet., 1984, 13, 181.
20. Kaplan E.L., Meier P.: "Nonparametric estimation from incomplete observations". J. Am. Stat. Assoc., 1985, 53, 457.
21. Goppinger A., Freudenberg N., Ross A., Hillemans H.G., Hilgarth M.: "The prognostic significance of the DNA distribution in squamous-cell carcinomas of the uterine cervix". The International Academy of Cytology Analytical and Quantitative Cytology and Histology, 1986, 8, 148.
22. Naus G.J., Zimmerman R.L.: "Prognostic value of flow cytophotometric DNA content analysis in single treatment Stage IB-IIA squamous cell carcinoma of the cervix". Gynecol. Oncol., 1991, 43, 149.
23. Kenter G.G., Cornelisse C.J., Aartsen E.J. et al.: "DNA ploidy level as prognostic factor in low stage carcinoma of the uterine cervix". Gynecol. Oncol., 1990, 39, 181.
24. Benedet J.L., Odicino F., Maisonneuve P. et al.: "Carcinoma of the cervix uteri". J. Epidemiol. Biostat., 2001, 6, 7.
25. Yu J.M., Zhang H., Wang S.Q. et al.: "DNA ploidy analysis of effectiveness of radiation therapy for cervical carcinoma". Cancer. 1991, 68, 76.
26. Davis J.R., Aristizabal S., Way D.L. et al.: "DNA ploidy, grade, and stage in prognosis of uterine cervical cancer". Gynecol. Oncol., 1989, 32, 4.
27. Lutgens L.C., Schutte B., de Jong, J.M., Thunnissen F.B.: "DNA content as prognostic factor in cervix carcinoma Stage IB-III treated with radiotherapy". Gynecol. Oncol., 1994, 54, 275.